Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

World News

Brazilian leader Lula released from hospital after suffering vertigo

by admin May 27, 2025
May 27, 2025
Brazilian leader Lula released from hospital after suffering vertigo

Brazil’s President Luiz Inácio Lula da Silva was diagnosed with labyrinthitis Monday after suffering from vertigo, hospital officials said.

The 79-year-old leftist leader has already returned to the country’s presidential residence, where he is resting.

The Sirio-Libanes Hospital said in a statement that Lula underwent imaging and blood tests, and its results came within normal limits. Labyrinthitis is an inflammation of the labyrinth in the inner ear, which is responsible for hearing and balance.

The health scare adds to Lula’s recent medical worries, which are also part of his allies’ concerns ahead of his likely bid for reelection next year.

The most serious is a fall he had in the bathroom of the presidential residence in Brasília on Oct. 19.

Almost two months later, he was transferred to São Paulo for surgery after suffering headaches caused by new a bleeding in his head.

He was discharged Dec. 15.

This post appeared first on cnn.com

previous post
Hong Kong’s baby pandas finally get names. Meet Jia Jia and De De
next post
Phase 1 Drill Program – Operational and Geological Progress Update

Related Posts

Germany and other allies lift restrictions on Ukraine...

May 27, 2025

Blackwater founder Erik Prince joins security operation in...

April 6, 2025

Energy is the ‘number one problem’ for Africa’s...

May 6, 2025

Meet the Welsh puppies that are stopping wildlife...

April 23, 2025

Arab leaders endorse counterproposal to Trump’s Gaza plan,...

March 5, 2025

Israel stops humanitarian aid into Gaza after Hamas...

March 2, 2025

Deadly Israeli strikes mar Gaza Eid celebrations as...

March 31, 2025

Israel’s justice minister moves to oust attorney general...

March 6, 2025

14 killed in worst Russian strikes on Kyiv...

June 17, 2025

Four bodies transferred to Red Cross by Hamas,...

February 27, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved